Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
5(26%)
Results Posted
44%(4 trials)
Terminated
2(11%)

Phase Distribution

Ph not_applicable
12
63%
Ph phase_2
1
5%
Ph early_phase_1
2
11%
Ph phase_3
1
5%
Ph phase_4
2
11%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
2(11.1%)
Phase 2Efficacy & side effects
1(5.6%)
Phase 3Large-scale testing
1(5.6%)
Phase 4Post-market surveillance
2(11.1%)
N/ANon-phased studies
12(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

5

trials recruiting

Total Trials

19

all time

Status Distribution
Active(6)
Completed(9)
Terminated(3)
Other(1)

Detailed Status

Completed9
Recruiting4
Terminated2
unknown1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
5
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (11.1%)
Phase 21 (5.6%)
Phase 31 (5.6%)
Phase 42 (11.1%)
N/A12 (66.7%)

Trials by Status

completed947%
unknown15%
withdrawn15%
not_yet_recruiting15%
terminated211%
active_not_recruiting15%
recruiting421%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04604509Phase 4

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Recruiting
NCT03691350Early Phase 1

Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs

Completed
NCT05144542Not Applicable

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

Active Not Recruiting
NCT03856515Not Applicable

Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes

Completed
NCT05589220Not Applicable

Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Students

Recruiting
NCT06534047Phase 4

Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial

Recruiting
NCT02964182Not Applicable

Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers

Completed
NCT04694846Not Applicable

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Completed
NCT07059377Phase 3

Semaglutide for Smoking Cessation in Patients With Diabetes

Not Yet Recruiting
NCT06260683Not Applicable

A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior

Recruiting
NCT03808818Not Applicable

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Completed
NCT06745154Not Applicable

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

Completed
NCT05412875Not Applicable

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Withdrawn
NCT06130423Not Applicable

Study to Evaluate Music Therapy and Nicotine Replacement Therapy on Craving Related to Smoking Cessation in Health Staff

Unknown
NCT04297332Not Applicable

Episodic Future Thinking and Future Thinking Priming for Smoking Cessation

Terminated
NCT05873738

Smoking Cessation in a Cohort HIV+ Rio de Janeiro, Brazil.

Completed
NCT02582008Early Phase 1

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Terminated
NCT00469885Phase 2

Reduction of Smoking in Cardiac Disease Patients

Completed
NCT01734330Not Applicable

Cognitive Behaviour Therapy and Nicotine Replacement to Increase Tobacco Cessation

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19